Document is current
Any future updates will be listed below
-
Authors
Li, Xinyu
Achten, Anouk
Nassiri, Soufiane
Mourmans, Sanne
van de Bovenkamp, Arno A.
Knackstedt, Christian
Handoko, M. Louis
Weerts, Jerremy https://orcid.org/0000-0002-9369-3453
van Empel, Vanessa
-
Funding
Funding for this research was provided by:
AstraZeneca
- License Information
-
More Information
Article History
Received: 22 May 2025
Accepted: 10 October 2025
First Online: 4 November 2025
Conflict of interest
: A. Achten reports grants and personal fees from Pfizer and Alnylam, outside the submitted work paid to the institution. C. Knackstedt reports personal fees from Pfizer and, personal fees from Alnylam paid to the institution, grants and personal fees from Philips/TOMTEC Imaging systems, personal fees from Bristol Myers Squibb, grants from Boehringer Ingelheim, grants from AstraZeneca, outside the submitted work paid to the institution. M.L. Handoko reports grants and personal fees from Novartis, grants and personal fees from Boehringer Ingelheim, grants and personal fees from Vifor Pharma, personal fees from AstraZeneca, personal fees from Bayer, personal fees from MSD, personal fees from Abbott, outside the submitted work. J. Weerts reports grants from Corvia Medical, CSL Vifor, and Boehringer Ingelheim, outside the submitted work. V. van Empel reports grants and personal fees from Bayer, grants from Roche Diagnostics, grants from Vifor, personal fees from Novartis, personal fees from AstraZeneca, personal fees from Merck, personal fees from Janssen, outside the submitted work. X. Li, S. Nassiri, S. Mourmans and A.A. van de Bovenkamp declare that they have no competing interests.
